Electrode deployment mechanism and method using artificial muscle

• US 5,578,069 A
• Filed: 12/06/1995
• Issued: 11/26/1996
• Est. Priority Date: 12/06/1995
• Status: Expired due to Fees

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Vnetritex Incorporated
• Inventors: Miner, William D. II
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Layno, Carl H.
• Application Number:
  US08/568,046
• Time in Patent Office: 356 Days
• Field of Search: 607/119, 607/122, 607/123, 607/126, 607/128
• US Class Current: 607/126
• CPC Class Codes: A61N 1/0504 Subcutaneous electrodes
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/3962 in combination with another heart therapy
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A lead having a defibrillation electrode that is deployed for defibrillation using artificial muscle. In an undeployed position, the defibrillation electrode is small in diameter so as to be easily implanted pervenously and nonobstructive to cardiac contraction and blood flow. In a deployed position the defibrillation electrode is larger in diameter for defibrillation shock delivery. Thus, the electrode forces an increased amount of current to flow through the heart muscle during shock delivery to depolarize the majority of the cardiac tissue with a minimum of energy, while not obstructing blood flow at other times when not used for energy delivery.

Claims

1. A deployment mechanism for an implantable deployable electrode, comprising:

at least one artificial muscle element mechanically coupled to the deployable electrode; and

means for applying a voltage across said artificial muscle element causing said artificial muscle element to contract such that the deployable electrode is deployed.

2. The deployment mechanism of claim 1, further comprising an insulation means for electrically insulating said artificial muscle element from the deployable electrode.

3. The deployment mechanism of claim 1, and further including means for enhancing the return of the deployable electrode to its initial condition.

4. The deployment mechanism of claim 3, wherein said means for enhancing the return of the deployable electrode includes a spring.

5. The deployment mechanism of claim 3, wherein said means for enhancing the return of the deployable electrode includes means for reversing the polarity of the voltage across said artificial muscle element.

6. The deployment mechanism of claim 1, wherein said artificial muscle element comprises a polyelectrolyte gel.

7. The deployment mechanism of claim 1, wherein said artificial muscle element comprises a material selected from the group consisting of:

poly(2-acrylamido-2-methylpropanesulfonic acid) (PAMPS) gel and polyacrylic acid plus sodium acrylate cross-linked with bisacrylamide (PAAM).

8. A lead for implantation in a patient comprising:

a connector at a proximal end of said lead for connection to a pulse generator;

a lead body having an insulated conductor electrically coupled to said connector;

a deployable electrode electrically coupled to said conductor;

an artificial muscle element mechanically coupled to said deployable electrode; and

means for applying a voltage across said artificial muscle element causing said artificial muscle element to contract such that said deployable electrode is deployed.

9. The lead of claim 8, wherein said means for applying a voltage comprises a first artificial muscle element conductor electrically coupled to a first end of said artificial muscle element and a second artificial muscle element conductor electrically coupled to a second end of said artificial muscle element.

10. The lead of claim 8, further comprising an insulation means for electrically insulating said artificial muscle element from said deployable electrode.

11. The lead of claim 8, and further including means for returning the deployable electrode to its initial condition.

12. The lead of claim 11, wherein said means for returning the deployable electrode includes a spring.

13. The lead of claim 11, wherein said means for returning the deployable electrode includes means for reversing the polarity of the voltage across said artificial muscle element.

14. The lead of claim 8, wherein said artificial muscle element comprises a polyelectrolyte gel.

15. The lead of claim 8, wherein said artificial muscle element comprises a material selected from the group consisting of:

poly(2-acrylamido-2-methylpropanesulfonic acid) (PAMPS) gel and polyacrylic acid plus sodium acrylate cross-linked with bisacrylamide (PAAM).

16. A stimulation system, comprising:

a pulse generator for generating electrical energy;

a lead having a deployable electrode electrically connected to said pulse generator and at least one artificial muscle element for expanding said deployable electrode from a nondeployed state to a deployed state; and

control means for sensing an episode requiring therapeutic electrical pulses and for supplying a voltage across said artificial muscle element to deploy said deployable electrode during said episode and for causing said pulse generator to generate said therapeutic electrical pulses through said deployable electrode.

17. The cardiac stimulation system of claim 16, wherein said deployable electrode comprises an endocardial right ventricular defibrillation electrode.

18. The cardiac stimulation system of claim 16, wherein said lead further includes a nondeployable defibrillation electrode.

19. The cardiac stimulation system of claim 16, wherein said artificial muscle element comprises a polyelectrolyte gel.

20. The cardiac stimulation system of claim 16, wherein said artificial muscle element comprises a material selected from the group consisting of:

poly(2-acrylamido-2-methylpropanesulfonic acid) (PAMPS) gel and polyacrylic acid plus sodium acrylate cross-linked with bisacrylamide (PAAM).

21. The cardiac stimulation system of claim 16, wherein said control means further includes means for adjusting the amount of voltage supplied across said artificial muscle element to control the degree to which said deployable electrode is deployed.

22. A method for deploying an electrode in a patient comprising the steps of:

(a) providing at least one artificial muscle element mechanically attached to the electrode; and

(b) applying a voltage across said artificial muscle element to cause said artificial muscle element to contract and deploy the electrode.

23. The method of claim 22, wherein the voltage applied in step (b) is 10 volts or less.

24. A method for defibrillating a patient'"'"'s heart comprising the steps of:

(a) applying a voltage across at least one artificial muscle element to deploy a defibrillation electrode; and

(b) delivering a defibrillation pulse through the defibrillation electrode.

25. The method of claim 24 and further including the step of:

(c) returning the defibrillation electrode to its initial position.

26. The method of claim 24 wherein the voltage applied in step (a) is 10 volts or less.